NHE3 is the dominant Na+/H+ exchanger in small intestine (1), and the NHE3 inhibitor tenapanor was recently approved for treatment of irritable bowel syndrome with constipation (2). The gene discussed is SLC9A3; the disease is irritable bowel syndrome.